Literature DB >> 31797779

Multiplicity in oncology randomised controlled trials: a threat to medical evidence?

Vinay Prasad1, Christopher M Booth2.   

Abstract

Year:  2019        PMID: 31797779     DOI: 10.1016/S1470-2045(19)30744-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

Review 1.  Rethinking clinical oncology drug research in an era of value-based cancer care: A role for chemotherapy pathways.

Authors:  J Russell Hoverman
Journal:  Cancer Med       Date:  2020-06-10       Impact factor: 4.452

2.  Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic.

Authors:  Ramez Kouzy; Joseph Abi Jaoude; Carolina J Garcia Garcia; Molly B El Alam; Cullen M Taniguchi; Ethan B Ludmir
Journal:  JAMA Netw Open       Date:  2020-07-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.